Price Gouging and Research Costs in the Pharmaceutical Industry ERALD KOLASI

Excellent piece.

See this iconic examination: Lazonick, William, Matt Hopkins, Matthew Frye Jacobson, Mustafa Sakinc, and Oner Tulum. “US Pharma’s Financialized Business Model.” Institute for New Economic Thinking Working Papers, no. No. 60 (July 13, 2017): 28.